Palavras-chave
Como Citar
Resumo
O câncer de mama representa cerca de 24,5% de todos os diagnósticos de câncer e 15,5% das mortes relacionadas à doença, sendo a principal causa mortalidade na maioria dos países, a quimioterapia é considerada a abordagem terapêutica padrão ouro para o câncer de mama, contudo, evidências indicam que esse método pode provocar não apenas reações adversas físicas, mas também dificuldades cognitivas associadas ao tratamento. Objetivo: identificar evidências sobre as repercussões da quimioterapia na função cognitiva de mulheres com câncer de mama. Metodologia: Trata-se de uma revisão integrativa, exploratória e descritiva, na qual a coleta de informações nas seguintes bases de dados: LILACS, Google Acadêmico, e Periódicos da Capes, foram selecionados artigos datados entre 2018 a 2014. Resultados: Foram selecionados 8 artigos para compor a pesquisa. Conclusão: A quimioterapia repercute reduzindo de forma significativa a função e desempenho cognitivo de mulheres com câncer de mama, isso tem impacto latente nas atividades de vida diárias, pior desempenho em suas atividades laborais e qualidade de vida em um contexto geral.
Referências
ARNOLD, M. et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. The Breast, v. 66, p. 15-23, 2022.
BOSCHER, C. et al. Perceived cognitive impairment in breast cancer survivors and its relationships with psychological factors. Cancers, v. 12, n. 10, p. 3000, 2020.
CHEN, V. C. et al. Association of Longitudinal Changes in Cerebral Microstructure with Cognitive Functioning in Breast Cancer Survivors after Adjuvant Chemotherapy. Journal of Clinical Medicine, v. 13, n. 3, p. 668, 2024.
DING, K. et al. Managing cancer and living meaningfully (CALM) intervention on chemotherapy-related cognitive impairment in breast cancer survivors. Integrative cancer therapies, v. 19, p. 1534735420938450, 2020.
DURÁN-GÓMEZ, N. et al. Chemotherapy-related cognitive impairment in patients with breast cancer based on functional assessment and NIRS analysis. Journal of clinical medicine, v. 11, n. 9, p. 2363, 2022.
HENDERSON, F. M.; CROSS, A. J.; BARANIAK, A. R. ‘A new normal with chemobrain’: Experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors. Health psychology open, v. 6, n. 1, p. 2055102919832234, 2019.
KOEVOETS, E. W. et al. Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study). Breast cancer research, v. 24, n. 1, p. 36, 2022.
LEI, S. et al. Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020. Cancer Communications, v. 41, n. 11, p. 1183-1194, 2021.
MARTÍN, B. R. et al. Study of chemotherapy-induced cognitive impairment in women with breast cancer. International Journal of Environmental Research and Public Health, v. 17, n. 23, p. 8896, 2020.
OLIVEIRA, A. F. et al. Perceived cognitive functioning in breast cancer patients treated with chemotherapy compared to matched healthy women: Evidence from a Portuguese study. International Journal of Nursing Practice, v. 29, n. 3, p. e13119, 2023.
OLIVEIRA, M. E. C. et al. Cognitive impairments associated with chemotherapy in women with breast cancer: a meta-analysis and meta-regression. Brazilian Journal of Medical and Biological Research, v. 56, p. e12947, 2023.
REN, X. et al. Effects of physical exercise on cognitive function of breast cancer survivors receiving chemotherapy: A systematic review of randomized controlled trials. The Breast, v. 63, p. 113-122, 2022.
SANTOS, C. M. C.; PIMENTA, C. A. M.; NOBRE, M. R. C. A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Revista latino-americana de enfermagem, v. 15, p. 508-511, 2007.
SYARIF, H.; WALUYO, A.; AFIYANTI, Y.. Cognitive perception among post-chemotherapy, non-chemotherapy breast cancer survivors and non-cancer. Asian Pacific Journal of Cancer Prevention: APJCP, v. 22, n. 6, p. 1775, 2021.
VAN DER WILLIK, K. D. et al. Inflammation markers and cognitive performance in breast cancer survivors 20 years after completion of chemotherapy: a cohort study. Breast Cancer Research, v. 20, p. 1-10, 2018.
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Rodrigo da Silva Bezerra, Cibele Avila Gomes, Ana Thaís de Melo Oliveira, Karolayne da Silva Barbosa, Ozarlan Michel Pereira de Oliveira , Laura Vieira Corrêa, José Renen Sousa Cruz, Leandro Guimarães Borges, Anyelle Araújo Cardoso Bento , Aline Duarte Rodrigues, Norma Ayala Zarate, Alex de Souza Borges, Rodrigo Daniel Zanoni